Synapse - Breast Medicine Service

Results (4181)

B-RAF mutation is associated with altered patterns of negative feedback of MAPK signaling that correlate with increased output of the pathway and increased sensitivity to MEK inhibition

Meeting Abstract

Pratilas, C.; Grbovic, O.; Zhao, H.; Viale, A.; Solit, D.; Rosen, N.
EJC Supplements (2006)

Fulltext@MSK | Save

Study participants' perceptions of the process and impact of receiving results of N9831

Meeting Abstract

Partridge, A. H.; Wolff, A. C.; Marcom, P. K.; Kaufman, P. A.; Moore, C.; Lake, D.; Fleming, G.; Rugo, H. S.; Collyar, D.; Winer, E. P.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

A pilot study to assess the tolerability and efficacy of RAD-001 (everolimus) with gefitinib in patients with recurrent glioblastorna multiforme (GBM)

Meeting Abstract

Nguyen, T. D.; Lassman, A. B.; Lis, E.; Rosen, N.; Shaffer, D. R.; Scher, H. I.; Deangelis, L. M.; Abrey, L. E.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

A pilot study to assess the tolerability and efficacy of RAD-001 (everolimus) with gefitinib in patients with recurrent glioblastoma multiforme (GBM)

Meeting Abstract

Nguyen, T. D.; Lassman, A. B.; Lis, E.; Rosen, N.; Shaffer, D. R.; Scher, H. I.; Deangelis, L. M.; Abrey, L. E.
Neuro-Oncology (2006)

Fulltext@MSK | Save

Quality of life (QOL) companion to CALGB 9840: A phase III study of paclitaxel (P) via weekly 1 hour (hr) versus standard 3 hour infusion every 3 weeks with trastuzumab in the treatment of patients with/without HER-2/neu-overexpressing metastatic breast cancer

Meeting Abstract

Naughton, M. J.; Gu, L.; Wang, X. F.; Seidman, A. D.; Winer, E.; Kornblith, A. B.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Toxicity of older and younger patients (pts) treated (Rx) with intensive adjuvant chemotherapy (Cx) for node-positive (N plus ) breast cancer (BC): The CALGB experience